Timing of onset of antidepressant response with fluoxetine treatment

被引:193
作者
Nierenberg, AA [1 ]
Farabaugh, AH [1 ]
Alpert, JE [1 ]
Gordon, J [1 ]
Worthington, JJ [1 ]
Rosenbaum, JF [1 ]
Fava, M [1 ]
机构
[1] Massachusetts Gen Hosp, Depress & Clin Res Program, Boston, MA 02114 USA
关键词
D O I
10.1176/appi.ajp.157.9.1423
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: The purpose of this study was to assess the time until onset of antidepressant response with fluoxetine treatment. Method: The authors evaluated 182 outpatients with major depression who had a sustained acute response to fluoxetine treatment. The Outpatients received 8 weeks of treatment with 20 mg/day of fluoxetine and were assessed biweekly with the 17-item Hamilton Depression Rating Scale. The onset of response was defined as a 30% decrease in score on the Hamilton depression scale that persisted and led to a 50% decrease by week 8. The Kaplan-Meier product limit and Cox regression analysis were used to model the relationship between relevant variables and time until onset of response. Results: The authors found that at weeks 2, 4, and 6, the probabilities of having an onset of response (for responders) were 55.5%, 24.7%, and 9.3%, respectively. The cumulative probabilities of onset of response at each time point were 55.5%, 80.2%, and 89.5%,Neither demographics nor clinical characteristics of depression predicted time until initial response. Conclusions: These data suggest that more than half of eventual responders to fluoxetine treatment at 8 weeks start to respond by week 2; over 75% start to respond by week 4. Conversely, the lack of onset of response at 4-6 weeks was associated with about a 73%-88% chance that patients would not have an onset of response by 8 weeks.
引用
收藏
页码:1423 / 1428
页数:6
相关论文
共 34 条
[11]  
HEKIMIAN LJ, 1978, J CLIN PSYCHIAT, V39, P633
[12]  
Hyman SE, 1996, AM J PSYCHIAT, V153, P151
[13]   NONPARAMETRIC-ESTIMATION FROM INCOMPLETE OBSERVATIONS [J].
KAPLAN, EL ;
MEIER, P .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1958, 53 (282) :457-481
[14]   THE TIMING, SPECIFICITY AND CLINICAL-PREDICTION OF TRICYCLIC DRUG EFFECTS IN DEPRESSION [J].
KATZ, MM ;
KOSLOW, SH ;
MAAS, JW ;
FRAZER, A ;
BOWDEN, CL ;
CASPER, R ;
CROUGHAN, J ;
KOCSIS, J ;
REDMOND, E .
PSYCHOLOGICAL MEDICINE, 1987, 17 (02) :297-309
[15]  
LASKA EM, 1995, PSYCHOPHARMACOL BULL, V31, P29
[16]  
LEBER P, 1995, PSYCHOPHARMACOL BULL, V31, P37
[17]  
MISCHOULON D, 1997, AM SOC CLIN PSYCHOPH, V8, P9
[18]   How to assess the onset of antidepressant effect: Comparison of global ratings and findings based on depression scales [J].
Moller, HJ ;
Muller, H ;
Volz, HP .
PHARMACOPSYCHIATRY, 1996, 29 (02) :57-62
[19]   A controlled study of the efficacy and safety of mianserin and amitriptyline in depressive inpatients [J].
Moller, HJ ;
Kasper, S ;
Muller, H ;
Kissling, W ;
Fuger, J ;
Ruhrmann, S .
PHARMACOPSYCHIATRY, 1995, 28 (06) :249-252
[20]  
MONTGOMERY SA, 1995, PSYCHOPHARMACOL BULL, V31, P41